Clinical trial
Evaluation of the Precision and Accuracy of International Normalised Ratio (INR) Measurements as Assessed by the LumiraDx Instrument in a Professional Point of Care Setting With Multiple Operators
NCT03682419 is registered in ClinicalTrials.gov with LumiraDx UK Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Precision and Accuracy of International Normalised Ratio (INR) Measurements as Assessed by the LumiraDx Instrument in a Professional Point of Care Setting With Multiple Operators
- Lead sponsor
- LumiraDx UK Limited
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 17, 2018
- Completion date
- November 23, 2018
- Enrollment
- 420 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
antiphospholipid syndrome, artificial heart device user, atrial fibrillation, deep vein thrombosis, post-myocardial infarction syndrome, pulmonary embolism, thrombophilia